Sutimlimab
Sutimlimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Sutimlimab is under investigation in clinical trial NCT03347422 (A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion (Cadenza Study)).
| Trade Name | Sutimlimab |
| Availability | Prescription only |
| Generic | Sutimlimab |
| Sutimlimab Other Names | Sutimlimab |
| Related Drugs | Enjaymo |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Sutimlimab
